CD8A and neoplasm: The tumors showed reduced CD8 T cell infiltration (CD8 TILs) and lower IFNγ in the recTLT-1–injected mice (Fig. 4, E and F), supporting increased tumor growth and compromised antitumor response by CD8 T cells in these mice.